Clinical trials for the blood substitute PolyHeme exposed the possibility for ambiguous interpretation of the FDA’s waiver of informed consent for emergency research.
The current Medicare operation—reimbursing medical goods and services to a growing number of people without basing the reimbursement benefit on the actual cost of the services—is unsustainable, but there are some possible remedies.
An ethical case explores a lawsuit against Fred Hutchinson Cancer Center of Seattle by patients who claimed they were not told of the full risks associated with a clinical trial they participated in.
Lynn P. Freedman, JD, MPH, Rana E. Barar, and Ann M. Drobnik, MPH
Physicians should play a critical role in expanding access to reproductive health choices for women, including the choice to give birth under the care of a midwife.